Uric acid in Type 2 Diabetes mellitus with nephropathy

Journal Title: International Journal of Clinical Biochemistry and Research - Year 2016, Vol 3, Issue 3

Abstract

Introduction: Uric acid is an important antioxidant that contributes for around 60% of free radical scavenging capacity of serum. Its role has been controversial in type 2 diabetes mellitus. Earlier studies have reported that renal disease leads to elevation of uric acid in DM, but recently high uric acid levels are reported to be risk factor for the development of diabetes mellitus. Aim of our study is to compare uric acid in type 2 DM with renal disease with non-diabetics and also to compare its levels among patients in different stages of diabetic nephropathy. Methodology: The case control study was conducted in medical college hospital in coastal Karnataka. Data of serum uric acid, renal profile and demographic profiles of 89 type 2 diabetes mellitus patients was collected from the clinical biochemistry laboratory in the year 2016. Data of 80 non-diabetic controls was taken. Transasia XL-640 was used for the estimation.Estimated GFR (eGFR) was calculated using MDRD formula. Results: We found an elevation in uric acid and creatinine levels, extremely significantly lower eGFR in diabetics (P = 0.0195, P=0.0078 and P =0.0001respectively).Odd’s ratio was 3.128 between uric acid and diabetic nephropathy. A highly significant (P< 0.0016) differences was observed in uric acid levels among patients of different stages of diabetic nephropathy. Conclusion: Hyperuricemia was found in diabetic nephropathy patients. There was a significant difference in uric acid was observed among different stages of nephropathy. However causal relationship is inclusive. Prospective studies need to be designed with a serial monitoring of uric acid, GFR and microalbunuria in diabetics till the development of nephropathy to establish which the cause is and which is effect among these two factors (uric acid and diabetic nephropathy.

Authors and Affiliations

Usha Sachidananda Adiga, BN Malawadi

Keywords

Related Articles

Mathematical model of evaluation of Insulin Resistance using Homeostasis Model Assessment – Insulin Resistance Index in patients with Hyperthyroidism

Aim: To evaluate insulin resistance using HOMA-IR index in patients with overt and subclinical hyperthyroidism. Materials and Method: A randomized case control study on female population was conducted. For which 30 overt...

Reliability of blood gas analyzer for the measurement of electrolytes - A comparative study

Background: Electrolyte and blood gas analysis are essential for most patients who are admitted in the casualty. Routinely simultaneous arterial and venous sample would be sent to the laboratory for blood gas analysis an...

Study of serum zinc level in overt and subclinical hypothyroidism – A case control study

Introduction Hypothyroidism is a clinical condition which is characterized by low thyroid hormone synthesis It results in slowdown of metabolic processes and also presents with biochemical abnormalities including reduced...

Serum neutrophil gelatinase-associated lipocalin as an early biomarker of acute kidney injury in subjects undergoing percutaneous transluminal coronary angiogram with normal EGFR

Introduction: Detecting AKI in a timely fashion with the current AKIN staging criteria is a challenge because the diagnosis of AKI is usually based on changes in serum creatinine (SCr) which is a poor marker of early ren...

Evaluation of Adenosine deaminase, Serum C-reactive protein and alkaline phosphatase activity in Rheumatoid Arthritis patients in Shivamogga district, South India

Introduction & Objectives: Rheumatoid arthritis (RA) is a prototypical inflammatory joint disease. The degree of inflammation is reflected in the extent of joint damage, which further has influence on the quality of life...

Download PDF file
  • EP ID EP242897
  • DOI -
  • Views 72
  • Downloads 0

How To Cite

Usha Sachidananda Adiga, BN Malawadi (2016). Uric acid in Type 2 Diabetes mellitus with nephropathy. International Journal of Clinical Biochemistry and Research, 3(3), 340-342. https://europub.co.uk/articles/-A-242897